FAKTOR-ZERTIFIKAT - BIOGEN IDEC | Real-time Bid/Ask 18:36:46 23/05/2024 BST | ||
| 6.45 EUR / 6.46 EUR | +9.41% |
|
| Current month | -23.08% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 23/05/24 | 6.49 | +10.00% |
| 22/05/24 | 5.9 | +5.92% |
| 21/05/24 | 5.57 | +5.49% |
| 20/05/24 | 5.28 | -1.49% |
| 17/05/24 | 5.36 | +0.37% |
Delayed Quote Börse Stuttgart
Last update May 23, 2024 at 05:50 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | J.P. Morgan |
| WKN | JK7Z4V |
| ISIN | DE000JK7Z4V6 |
| Date issued | 26/04/2024 |
| Strike | 284.6 $ |
| Maturity | Unlimited |
| Parity | 9.67 : 1 |
| Emission price | 10.03 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.04 € |
|---|---|
| Lowest since issue | 4.87 € |
| Spread | 0.01 € |
| Spread % | 0.16% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
225.2
USD
Average target price
287.3
USD
Spread / Average Target
+27.57%
- Stock Market
- Certificates
- Certificat
